Ozaki术后瓣叶增厚与运动减低的患病率及临床意义
本研究基于2014至2016年东京Toho大学大桥医疗中心184例Ozaki手术患者,其中143例术后2周内经食管超声心动图质量合格。研究发现早期瓣叶增厚发生率为22%(32例),瓣叶运动减低为40%(57例),中位随访5.9年显示两者均未增加全因死亡或主动脉瓣再手术风险,瓣叶增厚也与平均跨瓣压差升高无关。
要点
- Ozaki术后早期瓣叶增厚发生率为22%,瓣叶运动减低为40%。
- 瓣叶增厚患者均合并瓣叶运动减低。
- 未升级抗血栓治疗下,中期结局与无增厚/运动减低者相当。
核心结论
- 未升级抗血栓治疗时,早期瓣叶增厚或运动减低患者的中期结局与无此现象者相当。
研究设计与样本
- 回顾性队列研究,纳入2014至2016年在东京Toho大学大桥医疗中心接受Ozaki手术的184例患者,其中143例术后2周内经食管超声心动图质量合格。
主要发现
- 143例中32例(22%)出现早期瓣叶增厚,57例(40%)出现瓣叶运动减低。
- 所有瓣叶增厚患者均存在瓣叶运动减低。
- 瓣叶增厚与全因死亡风险(P = .44)和主动脉瓣再手术风险(P = .44)均无差异,且与平均跨瓣压差升高无关(P = .39)。
关键数值与推荐
- 瓣叶增厚定义为与术中经食管超声相比新出现的高回声半月板样表现。
- 较小的主动脉窦尺寸和较高的低密度脂蛋白胆固醇水平与瓣叶增厚发生相关;瓣叶尺寸差异与瓣叶运动减低发生相关。
临床怎么用
- Ozaki术后早期瓣叶增厚和运动减低常见,在未升级抗血栓治疗下中期结局良好,但需进一步研究以确认其长期影响。
局限性
- 单中心回顾性研究,样本量有限,随访中位5.9年,未报告瓣叶增厚与运动减低的长期结构性瓣膜退化数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As with hypoattenuated leaflet thickening observed early after transcatheter aortic valve replacement, early cusp thickening and reduced cusp motion after the Ozaki procedure sometimes occur. METHODS: From 2014 to 2016, 184 patients underwent Ozaki procedures at Toho University Ohashi Medical Center (Tokyo, Japan). Of these patients, 143 had adequate quality transesophageal echocardiography (TEE) within 2 weeks postoperatively. Cusp thickening was defined as new hyperechoic meniscal appearance compared with the intraoperative TEE. The study investigated frequency of cusp thickening and reduced cusp motion and their effect on longitudinal valve performance and clinical outcomes during the subsequent median 5.9-year follow-up. RESULTS: Of the 143 patients, 32 (22%) experienced early cusp thickening, and 57 (40%) had reduced cusp motion. Neither condition resulted in escalation of antithrombotic therapy. All patients with cusp thickening had reduced cusp motion. Smaller aortic sinus size and higher low-density lipoprotein cholesterol levels were associated with the occurrence of cusp thickening and cusp size difference with the occurrence of reduced cusp motion. There was no difference in risk of all-cause mortality or aortic valve reoperation between patients with and without cusp thickening (P = .44 for both), and cusp thickening was not associated with higher mean gradients (P = .39). CONCLUSIONS: Without escalation of antithrombotic treatment, midterm outcomes of patients with early cusp thickening or reduced cusp motion were comparable to those without. This phenomenon is frequent, and although it appears benign, concern remains and requires further studies.
引用
- Hoshino Y, Hayama H, Frankel WC, et al. Prevalence and Clinical Significance of Cusp Thickening and Reduced Cusp Motion After the Ozaki Procedure. Ann Thorac Surg. 2026. PMID: 41831764. doi:10.1016/j.athoracsur.2026.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。